Biotech China 2014

View Profile


Speaking/Presenting-Abstract/Poster at Mtg

Topic Authors / presenters Event name Event date
1. Chemoprevention of Prostate Cancer by the Herbal Supplement EquiguardTM The First International Conference of the Modernization of Chinese Medicine. March, 2002
2. In vitro analysis of the anti-prostatic properties of dietary supplement EquiguardTM with herbal formulation PC-SPES 6th International Symposium on Predictive Oncology and Intervention Strategies. Pasteur Institute, Paris February, 2002
3. Changes in STAT1 and ERK by water and ethanol extracts of I’m-YunityTM(PSP) as mechanistic correlates of its clinical efficacy 6th International Symposium on Predictive Oncology and Intervention Strategies. Pasteur Institute, Paris February, 2002
4. Targeting cell cycle traverse, induction of apoptosis, and regulation of hormone receptors AR and ER-a by herbal formulations EquiguardTM and PC-SPES in the treatment of prostate cancer. Association for Cancer Re January, 2002
5. Antitumorigenic properties of mushroom extract I’m-YunityTM(PSP). Singapore Traditional Chinese Medicine (TCM) Research Symposium November, 2001
6. Nutrient supplement modulation of prostate carcinogenesis: comparative studies of herbal formulations EquiguardTM and PC-SPES Singapore Traditional Chinese Medicine (TCM) Research Symposium November, 2001
7. Clinical and laboratory research update on I’m-YunityTM(PSP), a protein-bound polysaccharide derived from mushroom Trametes versicolor. Center for Mind-Body Medicine conference, Comprehensive Cancer Care 2001: Integrating Complementary and Alternative Therapies October, 2001
8. Elucidation of the effects of each individual herb in PC-SPES on prostate cell growth and specific gene expression Center for Mind-Body Medicine conference, Comprehensive Cancer Care 2001: Integrating Complementary and Alternative Therapies October, 2001
9. PC-SPES controls hormone responsive prostate cancer cell growth by estradiol independent mechanism 11th Annual conference on Diet, Nutrition and Cancer July, 2001
10. Down regulation of NF-kB and Rb in relation to antiproliferative and apoptosis inducing properties of mushroom extract I’m-YunityTM. American Institute for Cancer Research. 11th Annual conference on Diet, Nutrition and Cancer July, 2001
11. Regulation of cell cycle progression, induction of apoptosis, and increased expression of secreted interleukin 1-beta (IL-1b) in HL-60 leukemia cells treated with water and ethanol extracts of mushroom Coriolus versicolor (Imyunity). American Institute for Cancer Research 10th Annual conference on Diet, Nutrition and Cancer. July, 2001
12. Mechanistic studies on ImyunityTM: a polysacchropeptide derived from mushroom (Coriolus versicolor) capable of suppressing growth and specific gene expression in human leukemia cells. Asian Therapies for Cancer 1st International Conference. March 1-3, 2001, New York, U.S.A. American Association for Cancer Research. 92nd Annual Meeting, March 24-28, 2001 March, 2001
13. Regulation of cell cycle progression, induction of apoptosis, and increased expression of secreted interleukin 1-beta (IL-1b) in HL-60 leukemia cells treated with water and ethanol extracts of mushroom Coriolus versicolor (Imyunity). American Association for Cancer Res., March 24-28, 2001. New Orleans March, 2001
14. Control of growth and expression of cell regulatory genes by onconase and interferon-beta in androgen-refractory JCA-1 human prostate cancer cells 3rd joint meeting of the ICS/ISICR. Nov 5-9, 2000 RAI-Amsterdam, The Netherlands November, 2000
15. Possible role of resveratrol in prevention of prostate carcinogenesis ISPO Meeting: Impact of biotechnology on cancer diagnostic and prognostic indicators. October, 2000
16. Gene responses to onconase in cultured Jurkat T cells The 5th World Congress on Advances in Oncology October, 2000
17. Control of cell growth, cell cycle traverse, and prostate specific gene expression The 5th World Congress on Advances in Oncology October, 2000
18. Modulation of signal transducer and activator of transcription (STAT) expression in HL-60 cells infected by the human granulocytic ehrlichiosis (HGE) agent ISICR meeting, Paris, September, 1999
19. Mechanism of action of 4-HPR 4th national conference of cancer epidemiology June, 1999
20. Suppression of intracellular oxidative stress by onconase Fifth International Meeting on Ribonucleases, Warrenton, VA January, 1999
21. In vitro susceptibility of the agent of human granulocytic ehrlichiosis 39th ICAAC meeting, abstract January, 1999
22. Cell cycle effects and induction of apoptosis caused by infection of HL-60 cells with human granulocytic ehrlichiosis (HGE) pathogen measured by flow and laser scanning cytometry (LSC). XIX Congress of the International Society for Analytical Cytology. Cytometry January, 1998
23. Grape-derived chemopreventive agent resveratrol decreases prostate-specific antigen (PSA) expression in LNCaP cells by an androgen receptor (AR)-independent mechanism AACR meeting January, 1998
24. Serologic evaluation of confirmed cases of human granulocytic ehrlichiosis (HGE) using human isolates as the source of antigens 38th ICAAC meeting, San Diego January, 1998
25. Clinical and laboratory features of patients with culture positive human granulocytic ehrlichiosis (HGE). 37th ICAAC meeting, Toronto January, 1997
26. ) The differential effects of retinoic acid and N-(4-hydroxyphenyl)retinamide on HL-60 cell growth, differentiation, and gene expression. American Society for Biochemistry and Molecular Biology, New Orleans January, 1996
27. Induction of apoptosis and altered expression of PSA in 4-hydroxyphenyl retinamide (4-HPR)-treated LNCaP prostatic cells American Society for Biochemistry and Molecular Biology, New Orleans January, 1996
28. The antiproliferative effects of nicotinamide and 3-aminobenzamide on human arterial smooth muscle cells 65th Scientific Sessions of the American Heart Association January, 1992
29. Cell density and interferon gamma effects on endothelin release by bovine pulmonary endothelial cells 65th Scientific sessions of the American Heart Association January, 1992
30. Cell density and interferon gamma effects on endothelin release by endothelial cells 65th Scientific sessions of the American Heart Association January, 1992
31. Stimulation of the phosphorylation of specific nuclear proteins in cultured Alzheimer's Disease fibroblasts by an interferon response element-activated protein kinase. 1992 meeting of the International Society for Interferon Research January, 1992
32. Analysis of chromatin structure and function in cultured Alzheimer's Disease (AD) fibroblasts: DNA methylation state associated with an IFN-inducible enzyme 2',5'-oligoadenylate (2-5A) synthetase Meeting of the International Society for Interferon Research January, 1991
33. Environmental challenges and serum mitogenic cativity for vascular smooth muscle cells 9th International Symposium on Atherosclerosis January, 1991
34. Modulation of human 2',5'-oligoadenylate (2-5A) synthetase gene expression by phorbol ester TPA Meeting of the International Society for Interferon Research January, 1990
35. Nuclear phosphoprotein changes during HL-60 cell differentiation into monocytes. FASEB January, 1988
36. Analysis of gamma interferon-suppressible proteins in human promyelocytic HL-60 leukemic cells International Symposium on Interferon Research. January, 1985
37. Partial purification and characterization of protein synthesizing inhibitors from rat liver mitochondria Federation Proceedings 40, 1215 January, 1981
38. Inhibitory effect of 2',5'-A oligoadenylate on erythropoietin-dependent colong formation. Blood, Supplement, Abstract 58, 101A January, 1981
39. Control of protein synthesis in rabbit reticulocytes: Possible involvement of a translational inhibitor in the inhibition of polypeptides synthesis by ethanol Federation Proceedings 40, 62 January, 1981
40. Translational inhibition by AMP in lysed rabbit reticulocytes. Federation Proceedings 39, 1391 January, 1980
41. Effect of interferon on DNA synthesis, poly(ADPR) polymerase and 2',5'-A polymerase in asynchronized and synchronized HeLa S3 cells. Federation Proceedings 39, 1859 January, 1980
42. Effect of hemin on Met-tRNAi deacylase and on (2'-5')An-activated endonuclease activities in lysed rabbit reticulocytes Federation Proceedings 39, 1376 January, 1980
43. 2',5'-oligo(cordycepin), an analog of 2',5'-oligo(A): Enzymatic synthesis, purification and characterization in lysed rabbit reticulocytes and HeLa cell extracts. Federation Proceedings 39, 910. January, 1980
44. Regulation of protein synthesis: Effect of phosphorylated sugars on the formation of expression of an inhibitor activated by oxidized glutathione Federation Proceedings 38, 2919 January, 1979
45. Regulation of protein synthesis in rabbit reticulocyte lysates: Effects of cAMP, sugar phosphates, dsRNA and pppA2'p5'A2'p5'A2'p5'A. Federation Proceedings 38, 2918 January, 1979
46. Regulation of protein synthesis: Role of NAD+ and sugar phosphates in lysed rabbit reticulocytes Miami Winter Symposium January, 1979
47. Coordination of protein and RNA synthesis in early germination of wheat embryos. Federation Proceedingss 37, 1249 January, 1978
48. Protein synthesis in lysed rabbit reticulocytes: Stimulation and inhibition by NAD Federation Proceedings 37, 1249 January, 1978
49. Adenosine 2'-epimerase, isolation, purification, ara A biosynthesis. Federation Proceedings 35, 2033 January, 1977
50. Effects of NAD+ and diphteria toxin on protein synthesis in rabbit reticulocyte lysates. Clinical Research 25, 543A January, 1977
51. Regulation of protein catabolizing and purine synthesizing enzymes in chick liver. Federation Proceedings 33, 1699 January, 1974



Site wide Speaking/Presenting-Abstract/Poster at Mtg

Presentation Event Month, Year
Resveratrol - a cardioprotective substance Resveratrol2010 September, 2010

4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.